Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors

Por Gupta, Jalaj, Igea, Ana, Papaioannou, Marilena, Lopez-Casas, Pedro Pablo, Llonch, Elisabet, Hidalgo, Manuel, Gorgoulis, Vassilis G., Nebreda, Angel R.
Publicado no Oncotarget (2015)

Monitoring vascular normalization induced by antiangiogenic treatment with 18F‐fluoromisonidazole‐PET

Por Hernández-Agudo, Elena, Mondejar, Tamara, Soto-Montenegro, Maria Luisa, Megías, Diego, Mouron, Silvana, Sanchez, Jesus, Hidalgo, Manuel, Lopez-Casas, Pedro Pablo, Mulero, Francisca, Desco, Manuel, Quintela-Fandino, Miguel
Publicado no Mol Oncol (2015)

Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models

Por Céspedes, María Virtudes, Guillén, María José, López-Casas, Pedro Pablo, Sarno, Francesca, Gallardo, Alberto, Álamo, Patricia, Cuevas, Carmen, Hidalgo, Manuel, Galmarini, Carlos María, Allavena, Paola, Avilés, Pablo, Mangues, Ramón
Publicado no Dis Model Mech (2016)

MT1-MMP as a PET Imaging Biomarker for Pancreas Cancer Management

Por Morcillo, Miguel Ángel, García de Lucas, Ángel, Oteo, Marta, Romero, Eduardo, Magro, Natalia, Ibáñez, Marta, Martínez, Alfonso, Garaulet, Guillermo, Arroyo, Alicia G., López-Casas, Pedro Pablo, Hidalgo, Manuel, Mulero, Francisca, Martínez-Torrecuadrada, Jorge
Publicado no Contrast Media Mol Imaging (2018)

PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data

Por Piñeiro-Yáñez, Elena, Reboiro-Jato, Miguel, Gómez-López, Gonzalo, Perales-Patón, Javier, Troulé, Kevin, Rodríguez, José Manuel, Tejero, Héctor, Shimamura, Takeshi, López-Casas, Pedro Pablo, Carretero, Julián, Valencia, Alfonso, Hidalgo, Manuel, Glez-Peña, Daniel, Al-Shahrour, Fátima
Publicado no Genome Med (2018)